Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
ICICI Direct’s analysis of Cipla’s Q3FY22 results
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The aim is to strengthen industry-academia cooperation
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
The last date to apply for this program is 18th January 2022
Subscribe To Our Newsletter & Stay Updated
